Mainz Biomed B.V.
Stock Forecast, Prediction & Price Target
Mainz Biomed B.V. Financial Estimates
Mainz Biomed B.V. Revenue Estimates
Mainz Biomed B.V. EBITDA Estimates
Mainz Biomed B.V. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $577.34K N/A | $529.87K -8.22% | $895.47K 68.99% | Avg: $4.27M Low: $2.29M High: $6.25M avg. 377.73% | Avg: $12.98M Low: $8.65M High: $17.62M avg. 203.55% | Avg: $44.80M Low: $29.87M High: $60.82M avg. 245.04% | Avg: $103.55M Low: $69.03M High: $140.57M avg. 131.11% |
Net Income
% change YoY
| $-12.07M N/A | $-26.45M -119.11% | $-26.29M 0.59% | Avg: $-46.19M Low: $-12.01M High: $-8.60M avg. -75.66% | Avg: $-41.39M Low: $-10.55M High: $-6.82M avg. 10.38% | Avg: $-5.03M Low: $-7.37M High: $-2.85M avg. 87.83% | Avg: $-649.69K Low: $-951.59K High: $-368.15K avg. 87.09% |
EBITDA
% change YoY
| $-9.26M N/A | $-25.65M -176.83% | $-25.01M 2.50% | Avg: $-3.88M Low: $-5.67M High: $-2.08M avg. 84.47% | Avg: $-11.78M Low: $-15.99M High: $-7.85M avg. -203.55% | Avg: $-40.66M Low: $-55.19M High: $-27.10M avg. -245.04% | Avg: $-93.97M Low: $-127.57M High: $-62.65M avg. -131.11% |
EPS
% change YoY
| -$1.67 N/A | -$1.87 -11.97% | -$1.62 13.36% | Avg: -$0.64 Low: -$0.74 High: -$0.53 avg. 60.80% | Avg: -$0.54 Low: -$0.65 High: -$0.42 avg. 15.74% | Avg: -$0.31 Low: -$0.45 High: -$0.18 avg. 42.05% | Avg: -$0.04 Low: -$0.06 High: -$0.02 avg. 87.09% |
Operating Expenses
% change YoY
| $9.55M N/A | $26.35M 175.78% | $27.15M 3.02% | Avg: $69.76M Low: $37.48M High: $102.03M avg. 156.90% | Avg: $211.76M Low: $141.17M High: $287.46M avg. 203.55% | Avg: $730.67M Low: $487.11M High: $991.85M avg. 245.04% | Avg: $1.68B Low: $1.12B High: $2.29B avg. 131.11% |
FAQ
What is Mainz Biomed B.V. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 27.41% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -12.01M, average is -46.19M and high is -8.60M.
What is Mainz Biomed B.V. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 239.36% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $2.29M, average is $4.27M and high is $6.25M.
What is Mainz Biomed B.V. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 51.42% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.74, average is -$0.64 and high is $-0.53.